MedPath

Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance

Not Applicable
Completed
Conditions
Healthy Aging
Interventions
Other: Cocoa flavanols and berries anthocyanins
Registration Number
NCT04348162
Lead Sponsor
National Research Council, Spain
Brief Summary

The study examines the effect of cocoa flavanols, red-berries anthocyanins or a combination of both on markers of cardiovascular health and cognition.

Detailed Description

The study examines the effect of cocoa flavanols, red-berries anthocyanins or a combination of both on markers of cardiovascular health and cognition.

Healthy volunteers are recruited to participate in a parallel study (n 30 per group) for 10 to 12 weeks. Markers of cardiovascular health (FMD, markers of inflammation and fatty acid metabolism) and cognition (neuropsychological tests and plasma neurotrophins) are being measured before and after intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Age 50-85
  • BMI 20-32 Kg/m2
Exclusion Criteria
  • Mini-mental state examination (MMSE) < 28
  • Systolic blood pressure (SBP) >139 mmHg
  • Diastolic blood pressure (DBP) > 89 mmHg
  • Total cholesterol > 6.5 mmol/L

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cocoa flavanols plus berries anthocyaninsCocoa flavanols and berries anthocyaninsCooa and red-berries are taken every day for 10-12 weeks.
Cocoa FlavanolsCocoa flavanols and berries anthocyaninsCocoa is taken every day for 10-12 weeks.
Berries anthocyaninsCocoa flavanols and berries anthocyaninsRed-berries are taken every day for 10-12 weeks.
Primary Outcome Measures
NameTimeMethod
Change from baseline of flow-mediated vasodilatation (FMD) of the brachial arteryOver 6 minutes on day 0 and after10 weeks

The FMD of the brachial artery will be measured using an ultrasound collected at baseline and continuously for 60 seconds post-arm occlusion for 5 minutes. FMD will be expressed as percentage of variation between pre-and postischemic diameters

Secondary Outcome Measures
NameTimeMethod
Change from baseline STROOP score after 10 weeks interventionat inclusion and 10 weeks after intervention

STROOP tests attention and executive function. This test aims to evaluate the inhibition of an automated process such as reading by asking participants to name the color of color names written in a different color ink.

For each participant SROOP results at inclusion will be compared with results after 10 weeks intervention

Change from baseline Tower of London score after 10 weeks interventionat inclusion and 10 weeks after intervention

Tower of London test consist of a three color game board that allows executive functioning evaluation by total time, time to first move and optimal moves change from participants inclusion to week 11.

Trial Locations

Locations (1)

Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC)

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath